Abstract
The Ehlers–Danlos syndrome (EDS) is a heterogeneous group of connective tissue disorders affecting skin and joint function. Molecular defects in extracellular matrix proteins, including collagen (type I, III, and V) and tenascin X are associated with different forms of EDS. Compound heterozygous mutations in the B4GALT7 gene, resulting in aberrant glycosylation of the dermatan sulfate proteoglycan decorin, had been described in a single patient affected with the progeroid form of EDS. We have studied the molecular phenotype of decorin, biglycan, and collagen type I containing fibrils in skin fibroblasts of a patient carrying the novel homozygous C808T point mutation in the B4GALT7 gene, which causes an Arg270Cys substitution in β4GalT-7. Compared to control fibroblasts, galactosyltransferase activity in β4GalT-7Arg270Cys cells was approximately three times reduced over a temperature range of 25–41°C. Pulse-chase experiments and confocal microscopy demonstrated that synthesis and secretion of decorin were normal in β4GalT-7Arg270Cys cells. However, about 50% of decorin were synthesized as a protein core in addition to its proteoglycan form. Biglycan was found in a monoglycanated form in addition to its mature form. Glycosaminoglycan chains were of the dermatan/chondroitin sulfate type both in β4GalT-7Arg270Cys and control cells, and epimerization was reduced for decorin and biglycan. Compared to control cells, β4GalT-7Arg270Cys cells showed altered, highly spread or stretched phenotypes and decreased proliferation rates. At the ultrastructural level, an intracellular accumulation of multiple secondary lysosomes and degenerative vacuoles was seen in β4GalT-7Arg270Cys cells. Furthermore, the collagen suprastructures were altered in the β4GalT-7Arg270Cys cells. The reduced β4GalT-7 activity resulting in defective glycosylation of decorin and biglycan may be responsible for the complex molecular pathology in β4GalT-7 deficient EDS patients, given the role of these proteoglycans in bone formation, collagen fibrillogenesis, and skeletal muscle development.
Similar content being viewed by others
References
Iozzo RV (1998) Matrix proteoglycans: from molecular design to cellular function. Annu Rev Biochem 67:609–652
Xu T, Bianco P, Fisher LW, Longenecker G, Smith E, Goldstein S, Bonadio J, Boskey A, Heegaard AM, Sommer B, Satomura K, Dominguez P, Zhao C, Kulkarni AB, Robey PG, Young MF (1998) Targeted disruption of the biglycan gene leads to an osteoporosis-like phenotype in mice. Nat Genet 20:78–82
Schönherr E, Sunderkötter C, Iozzo RV, Schaefer L (2005) Decorin, a novel player in the insulin-like growth factor system. J Biol Chem 280:15767–15772
Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF (2002) Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers–Danlos-like changes in bone and other connective tissues. J Bone Miner Res 17:1180–1189
Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV (1997) Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol 136:729–743
Kresse H, Rosthoj S, Quentin E, Hollmann J, Glössl J, Okada S, Tonnesen T (1987) Glycosaminoglycan-free small proteoglycan core protein is secreted by fibroblasts from a patient with a syndrome resembling progeroid. Am J Hum Genet 41:436–453
Quentin E, Gladen A, Rodèn L, Kresse H (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci USA 87:1342–1346
Okajima T, Fukumoto S, Furukawa K, Urano T (1999) Molecular basis for the progeroid variant of Ehlers–Danlos syndrome. Identification and characterization of two mutations in galactosyltransferase I gene. J Biol Chem 274:28841–28844
Almeida R, Levery SB, Mandel U, Kresse H, Schwientek T, Bennett EP, Clausen H (1999) Cloning and expression of a proteoglycan UDP-galactose:beta-xylose beta1,4-galactosyltransferase I. A seventh member of the human beta4-galactosyltransferase gene family. J Biol Chem 274:26165–26171
Götte M, Kresse H (2005) Defective glycosaminoglycan substitution of decorin in a patient with progeroid syndrome is a direct consequence of two point mutations in the galactosyltransferase I (β4Gal-T7) gene. Biochem Genet 43:67–79
Faiyaz-Ul-Haque M, Zaidi SH, Al Ali M, Al Mureikhi MS, Kennedy S, Al Thani G, Tsui LC, Teebi A (2004) A novel missense mutation in the galactosyltransferase-I (B4GALT7) gene in a family exhibiting facioskeletal anomalies and Ehlers–Danlos syndrome resembling the progeroid type. Am J Med Genet 128A:39–45
Walker LC, Teebi AS, Marini JC, De Paepe A, Malfait F, Atsawasuwan P, Yamauchi M, Yeowell HN (2004) Decreased expression of lysyl hydroxylase 2 (LH2) in skin fibroblasts from three Ehlers–Danlos patients does not result from mutations in either the coding or proximal promoter region of the LH2 gene. Mol Genet Metab 83:312–321
Seidler DG, Schaefer L, Robenek H, Iozzo RV, Kresse H, Schönherr E (2005) A physiologic three-dimensional cell culture system to investigate the role of decorin in matrix organisation and cell survival. Biochem Biophys Res Commun 332:1162–1170
Nareyeck G, Seidler DG, Troyer D, Rauterberg J, Kresse H, Schönherr E (2004) Differential interactions of decorin and decorin mutants with type I and type VI collagens. Eur J Biochem 27:3389–3398
Kresse H, Seidler DG, Müller M, Breuer E, Hausser H, Roughley PJ, Schönherr E (2001) Different usage of the glycosaminoglycan attachment sites of biglycan. J Biol Chem 276:13411–13416
Zamfir A, Seidler DG, Schönherr E, Kresse H, Peter-Katalinic J (2004) On-line sheathless capillary electrophoresis/nanoelectrospray ionization-tandem mass spectrometry for the analysis of glycosaminoglycan oligosaccharides. Electrophoresis 25:2010–2016
Seidler DG, Breuer E, Grande-Allen KJ, Hascall VC, Kresse H (2002) Core protein dependence of epimerization of glucuronosyl residues in galactosaminoglycans. J Biol Chem 277:42409–42416
Kassner A, Hansen U, Miosge N, Reinhardt DP, Aigner T, Bruckner-Tuderman L, Bruckner P, Grässel S (2003) Discrete integration of collagen XVI into tissue-specific collagen fibrils or beaded microfibrils. Matrix Biol 22:131–143
Hayashi Y, Liu C-Y, Jester JJ, Hayashi M, Wang I-J, Funderburgh JL, Saika S, Roughley PJ, Kao CW-C, Kao WW-Y (2005) Excess biglycan causes eyelid malformation by perturbing muscle development and TGF-alpha signaling. Dev Biol 277:222–234
Schaefer L, Babelova A, Kiss E, Hausser HJ, Baliova M, Krzyzankova M, Marsche G, Young MF, Mihalik D, Götte M, Malle E, Schaefer RM, Gröne HJ (2005) The matrix component biglycan is proinflammatory and signals through Toll-like receptors 4 and 2 in macrophages. J Clin Invest 115:2223–2233
Neame PJ, Choi HU, Rosenberg LC (1989) The primary structure of the core protein of the small, leucine-rich proteoglycan (PG I) from bovine articular cartilage. J Biol Chem 264:8653–8661
Taylor KR, Rudisill JA, Gallo RL (2005) Structural and sequence motifs in dermatan sulfate for promoting fibroblast growth factor-2 (FGF-2) and FGF-7 activity. J Biol Chem 280:5300–5306
Zou XH, Foong WC, Cao T, Bay BH, Ouyang HW, Yip GW (2004) Chondroitin sulfate in palatal wound healing. J Dent Res 83:880–885
Elenius V, Götte M, Reizes O, Elenius K, Bernfield M (2004) Inhibition by the soluble syndecan-1 ectodomains delays wound repair in mice overexpressing syndecan-1. J Biol Chem 279:41928–41935
Fushimi H, Kameyama M, Shinkai H (1989) Deficiency of the core proteins of dermatan sulphate proteoglycans in a variant form of Ehlers–Danlos syndrome. J Int Med 226:409–416
Wu J, Utani A, Endo H, Shinkai H (2001) Deficiency of the decorin core protein in the variant form of Ehlers–Danlos syndrome with chronic skin ulcer. J Dermatol Sci 27:95–103
Olguin HC, Santander C, Brandan E (2003) Inhibition of myoblast migration via decorin expression is critical for normal skeletal muscle differentiation. Dev Biol 259:209–224
Vesentini S, Redaelli A, Montevecchi FM (2005) Estimation of the binding force of the collagen molecule-decorin core protein complex in collagen fibril. J Biomech 38:433–443
Ferro DR, Provasoli A, Ragazzi M, Casu B, Torri G, Bossennec V, Perly B, Sinay P, Petitou M, Choay J (1990) Conformer populations of l-iduronic acid residues in glycosaminoglycan sequences. Carbohydr Res 195:157–167
Zamfir A, Seidler DG, Kresse H, Peter-Katalinic J (2003) Structural investigation of chondroitin/dermatan sulfate oligosaccharides from human skin fibroblast decorin. Glycobiology 13:733–742
Schönherr E, Witsch-Prehm P, Harrach B, Robenek H, Rauterberg J, Kresse H (1995) Interaction of biglycan with type I collagen. J Biol Chem 270:2776–2783
Lee PH, Trowbridge JM, Taylor KR, Morhenn VB, Gallo RL (2004) Dermatan sulfate proteoglycan and glycosaminoglycan synthesis is induced in fibroblasts by transfer to a three-dimensional extracellular environment. J Biol Chem 279:48640–48646
Alroy J, Jones MZ, Rutledge JC, Taylor JW, Toone J, Applegarth D, Hopwood JJ (1997) The ultrastructure of skin from a patient with mucopolysaccharidosis IIID. Acta Neuropathol (Berl) 93:210–213
Ohmi K, Greenberg DS, Rajavel KS, Ryazantsev S, Li HH, Neufeld EF (2003) Activated microglia in cortex of mouse models of mucopolysaccharidoses I and IIIB. Proc Natl Acad Sci USA 100:1902–1907
Acknowledgements
We thank Ms D. Holtfrerich, S. Budny, Ms M. Offers, Ms Y.G. Chan, Ms B. Pers, Ms G. Pentrup, and Ms P. Blumberg for their skilful technical assistance, and Dr. A. Superti-Furga, Dr. P. Bruckner, Dr. G. Fischer von Mollard, and the late Dr. H. Kresse for their helpful discussions. This work was financially supported by the Sonderforschungsbereich (SFB) 492 project A9 and A2, DFG GO1392/1-1 and IMF Se120202 of the University Hospital Münster, and the National Medical Research Council, Singapore.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Seidler, D.G., Faiyaz-Ul-Haque, M., Hansen, U. et al. Defective glycosylation of decorin and biglycan, altered collagen structure, and abnormal phenotype of the skin fibroblasts of an Ehlers–Danlos syndrome patient carrying the novel Arg270Cys substitution in galactosyltransferase I (β4GalT-7). J Mol Med 84, 583–594 (2006). https://doi.org/10.1007/s00109-006-0046-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00109-006-0046-4